Al
Aldel Bio
Cambridge MAFounded 202120 employees
Private CapbiotechPrivateRare Disease
Platform: Aldehyde Trap
Market Cap
N/A
All Drugs
4
Clinical Trials
6
Failed / Terminated
0
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| ALD-6159 | ALD-6159 | Phase 1 | 2 | Menin | MyelofibrosisIPF | ||
| Talalemzoparlimab | ALD-5777 | Approved | 1 | MALT1 | UC | ||
| ALD-7113 | ALD-7113 | Phase 3 | 2 | RET | Pompe | ||
| Datocapivasertib | ALD-1240 | NDA/BLA | 1 | PD-1 | Fabry |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)